The present study emulated a target trial to avoid immortal time and selection bias, chose a second-line glucose-lowering therapy as an active comparator to reduce confounding by indication, used an outcome definition based only on primary care records to minimize detection bias due to differential hospitalizations, and implemented a lag time to mitigate bias due to reverse causality
Improvements in muscle tone, body composition, cognitive clarity, and metabolic health typically continue to develop across three to six months as hormone levels stabilize
Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency
Find out what research has shown in the For Colds section of our Zinc Supplements Review
BOOK AN APPOINTMENT AFTER CLINIC HOURS: 55 AVENUE RD 204 A TORONTO, ON M5R 3L2 CANADA 162 CUMBERLAND ST 222 A TORONTO, ON M5R 1A8 CANADA